Christopher R. Frei, PharmD, MSc, BCPS

Articles by Christopher R. Frei, PharmD, MSc, BCPS

Patterns of Specific Testing for Patients With Chronic Myelogenous Leukemia

ByAllison M. Bell, PharmD, MSc, BCPS,Kristin M. Richards, PhD,Christopher R. Frei, PharmD, MSc, BCPS,Jim M. Koeller, MS

February 12th 2016

Study assessed chemotherapy use in patients with chronic myelogenous leukemia (CML) to determine how use of CML-specific tests impacted drug selection and modification.

Latest Updated Articles

Patterns of Specific Testing for Patients With Chronic Myelogenous Leukemia
Published: February 12th 2016 | Updated:

Christopher R. Frei, PharmD, MSc, BCPS

Articles by Christopher R. Frei, PharmD, MSc, BCPS

Patterns of Specific Testing for Patients With Chronic Myelogenous Leukemia

Latest Updated Articles

Trending on Pharmacy Times

FDA Approves Reformulated Ranitidine After 5-Year Absence

Zuranolone Offers New Hope for Postpartum Depression

Redefining the Role of GLP-1 Therapies: The Clinical Trials Behind the Expanding Indications

Updated Hypertension Guidelines Are Here

Fun Fact: Coffee Could Reduce Feelings of Depression